Anticancer Activity from Gold-alpha-Lactalbumin Nanoconstructs?
Source abstract
Abstract
Human α-Lactalbumin made lethal to tumor cells (HAMLET), and its bovine analogue BAMLET, have in the recent years shown promising results in cancer therapy. HAMLET contains several oleic acids which in turn stabilize a partially unfolded conformational state of the protein, inducing a higher surface activity compared to the native protein, and likely play a role in its cancer-detrimental function as well. Herein, we report the formation of gold-bovine α-lactalbumin nanoconstructs (Au–LA NCs) displaying conformational changes in the native protein and its concomitant ability to reduce HeLa cell viability approaching that of BAMLET. Modification of LA with gold was achieved via two synthesis protocols; (i) utilizing the intrinsic reduction potential of LA (Au–LAint) or (ii) the addition of an extrinsic reducing agent (Au–LAext). The gold–protein nanostructures formed were investigated using a palette of analytical probes including AFM, TEM, ζ-potential, UV–vis, circular dichroism, and fluorescence (steady-state and time-resolved). Toxicity toward HeLa cells was studied using a trypan blue assay and benchmarked against BAMLET. Whereas constructs from both synthetic protocols employed result in conformational changes of the protein and altered surface activity compared to the native protein, Au–LAint was found to display lipid-specific interaction and severe disruption of lipid monolayers. Au–LAint also revealed toxicity toward HeLa-cells comparable to that of BAMLET. The results imply that formation of Au–LA nanoconstructs could be a new route to making HAMLET-like materials, while also imparting a built-in optical probe from fluorescent or plasmonic gold species.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanocluster Synthesis and Applications · Advanced biosensing and bioanalysis techniques · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Ugelstad Laboratory, Department of Chemical Engineering, Norwegian University of Science and Technology (NTNU), N-7491 Trondheim, Norway
Department of Molecular Biology, University of Bergen, Thormøhlensgt 55 90, 5008 Bergen, Norway
References (45)
Show source-provided references
1. Rødland I. · BBA - Biomembranes · 2005 · 1717 · 1110.1016/j.bbamem.2005.09.004 ↗
2. Svensson M. · Protein Sci. · 2003 · 12 · 279410.1110/ps.0231003 ↗
3. Svensson M. · Proc. Natl. Acad. Sci. U.S.A. · 2000 · 97 · 422110.1073/pnas.97.8.4221 ↗
4. Svensson M. · J. Biol. Chem. · 1999 · 274 · 638810.1074/jbc.274.10.6388 ↗
5. Mossberg A.-K. · PLoS ONE · 2010 · 5 · e938410.1371/journal.pone.0009384 ↗
6. Lystvet S. M. · Soft Matter · 2011 · 7 · 1150110.1039/c1sm06337e ↗
7. Lystvet S. M. · Nanoscale · 2011 · 3 · 178810.1039/c0nr00948b ↗
8. Guével X. L. · J. Phys. Chem. C · 2011 · 115 · 1095510.1021/jp111820b ↗
9. Wen F. · Anal. Chem. · 2011 · 83 · 119310.1021/ac1031447 ↗
10. Shiang Y. C. · J. Mater. Chem. · 2012 · 22 · 1297210.1039/c2jm30563a ↗
11. Wang H.-H. · Int. J. Gerontology · 2012 · 6 · 110.1016/j.ijge.2011.09.015 ↗
12. Chen T. H. · Small · 2012 · 8 · 191210.1002/smll.201102741 ↗
13. Glomm W. R. · J. Disper. Sci. Technol. · 2005 · 26 · 38910.1081/DIS-200052457 ↗
14. Selvan S. T. · Langmuir · 2010 · 26 · 1163110.1021/la903512m ↗
15. Iosin M. · J. Mol. Struct. · 2009 · 924 · 19610.1016/j.molstruc.2009.02.004 ↗
16. Guével X. L. · Nanotechnology · 2011 · 22 · 275103/110.1088/0957-4484/22/27/275103 ↗
17. Xie J. · J. Am. Chem. Soc. · 2009 · 131 · 88810.1021/ja806804u ↗
18. Halskau Ø. · Proc. Natl. Acad. Sci. U.S.A. · 2008 · 105 · 862510.1073/pnas.0709881105 ↗
19. Halskau Ø. · J. Mol. Biol. · 2005 · 349 · 107210.1016/j.jmb.2005.04.020 ↗
20. Mossberg A.-K. · FEBS J. · 2010 · 277 · 461410.1111/j.1742-4658.2010.07890.x ↗
21. Glomm W. R. · J. Phys. Chem. B · 2005 · 109 · 80410.1021/jp049184k ↗
22. Xie H. · Anal. Chem. · 2003 · 75 · 579710.1021/ac034578d ↗
23. Lakowicz J. R. · 200610.1007/978-0-387-46312-4 ↗
24. Glomm W. R. · Anal. Chem. · 2009 · 81 · 304210.1021/ac8027257 ↗
25. Glomm W. R. · J. Phys. Chem. B · 2007 · 111 · 1432910.1021/jp074839d ↗
26. Volden S. · ACS Nano · 2010 · 4 · 118710.1021/nn901517u ↗
27. Link S. · J. Phys. Chem. B · 2002 · 106 · 341010.1021/jp014259v ↗
28. Sen T. · J. Phys. Chem. C · 2008 · 112 · 1794510.1021/jp806866r ↗
29. Militello V. · Biophys. Chem. · 2003 · 105 · 13310.1016/S0301-4622(03)00153-4 ↗
30. Volden S. · J. Phys. Chem. C · 2011 · 115 · 1139010.1021/jp2013072 ↗
31. Volden S. · RSC Adv. · 2012 · 2 · 1170410.1039/c2ra21931j ↗
32. Sreerama Narasimha · Protein Sci. · 1999 · 8 · 37010.1110/ps.8.2.370 ↗
33. Sethuraman A. · Proteins · 2004 · 56 · 66910.1002/prot.20183 ↗
34. Chakraborty H. · Biochemistry · 2012 · 51 · 100510.1021/bi300025c ↗
35. 10.1039/C2RA22479H10.1039/C2RA22479H ↗
36. Cornell D. G. · J. Colloid Interface Sci. · 1990 · 140 · 42810.1016/0021-9797(90)90363-S ↗
37. Yano Y. F. · J. Phys. Chem. Lett. · 2011 · 2 · 99510.1021/jz200111q ↗
38. Yano Y. F. · Langmuir · 2009 · 25 · 3210.1021/la803235x ↗
39. Rytömaa M. · J. Biol. Chem. · 1995 · 270 · 319710.1074/jbc.270.7.3197 ↗
40. Mattila J.-P. · Langmuir · 2008 · 24 · 415710.1021/la703940s ↗
41. Halskau Ø. · J. Mol. Biol. · 2002 · 321 · 9910.1016/S0022-2836(02)00565-X ↗
42. Guzmán E. · Colloid. Surface. A · 2012 · 413 · 17410.1016/j.colsurfa.2011.12.059 ↗
43. Bañuelos S. · J. Biol. Chem. · 1995 · 270 · 2991010.1074/jbc.270.50.29910 ↗
44. Storm P. · Oncogene · 2011 · 30 · 476510.1038/onc.2011.196 ↗
45. Permyakov S. E. · Biol. Chem. · 2012 · 393 · 8510.1515/BC-2011-230 ↗